Advanced search
Publication Cover
Health, Risk & Society Volume 13, 2011 - Issue 5: Drugs, Risk and Society
Submit an article Journal homepage
620
Views
16
CrossRef citations to date
0
Altmetric
Original articles: Risk regulation: Seeking to control the risk of drugs

A comparative analysis of risk management strategies in European Union and United States pharmaceutical regulation

Courtney Davis Department of Sociology, Centre for Research in Health and Medicine, University of Sussex, UKCorrespondence[email protected]
&
John Abraham Department of Sociology, Centre for Research in Health and Medicine, University of Sussex, UKCorrespondence[email protected]
Pages 413-431 | Received 05 Oct 2010, Accepted 11 Apr 2011, Published online: 05 Aug 2011

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Shelley K. White & Abigail N. Walters. (2018) Assessing risk by analogy: a case study of us medical device risk management policy. Health, Risk & Society 20:7-8, pages 358-378.
Read now
Reynold D. C. Francisca, Inge M. Zomerdijk, Miriam C. J. M. Sturkenboom & Sabine M. J. M. Straus. (2018) Measuring the impact of the 2012 European pharmacovigilance legislation on additional risk minimization measures. Expert Opinion on Drug Safety 17:10, pages 975-982.
Read now
David Demortain. (2015) The tools of globalization: ways of regulating and the structure of the international regime for pharmaceuticals. Review of International Political Economy 22:6, pages 1249-1275.
Read now
Valerie Leiter & Shelley K. White. (2015) Enmeshed in controversy: claims about the risks of vaginal mesh devices. Health, Risk & Society 17:1, pages 64-80.
Read now
Stuart Hogarth. (2012) Regulatory experiments and transnational networks: the governance of pharmacogenomics in Europe and the United States. Innovation: The European Journal of Social Science Research 25:4, pages 441-460.
Read now
Andy Alaszewski. (2011) Drugs, risk and society: Government, governance or governmentality?. Health, Risk & Society 13:5, pages 389-396.
Read now

Articles from other publishers (10)

Andrea Parziale. (2023) COVID-19 off-label uses of medicines: the role of civil liability and regulation. The Geneva Papers on Risk and Insurance - Issues and Practice 48:3, pages 669-686.
Crossref
Rhiannon Bandiera. (2021) Marx, Foucault, and state–corporate harm: a case study of regulatory failure in Australian non-prescription medicine regulation. Crime, Law and Social Change 76:2, pages 173-193.
Crossref
Alice L. Bhasale, Ameet Sarpatwari, Marie L. De Bruin, Joel Lexchin, Ruth Lopert, Priya Bahri & Barbara J. Mintzes. (2020) Postmarket Safety Communication for Protection of Public Health: A Comparison of Regulatory Policy in Australia, Canada, the European Union, and the United States. Clinical Pharmacology & Therapeutics 109:6, pages 1424-1442.
Crossref
Shai Mulinari & Courtney Davis. (2019) The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug Relenza. Social Studies of Science 50:1, pages 145-169.
Crossref
Christopher Ansell & Patrick Baur. (2018) Explaining Trends in Risk Governance: How Problem Definitions Underpin Risk Regimes. Risk, Hazards & Crisis in Public Policy 9:4, pages 397-430.
Crossref
Kathy Moscou & Jillian C. Kohler. 2018. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries 403 418 .
Boris Hauray. (2017) From Regulatory Knowledge to Regulatory Decisions: The European Evaluation of Medicines. Minerva 55:2, pages 187-208.
Crossref
Christine Hauskeller & Nicole Baur. 2017. Safety, Ethics and Regulations. Safety, Ethics and Regulations 201 216 .
Anna V. Zetterqvist, Juan Merlo & Shai Mulinari. (2015) Complaints, Complainants, and Rulings Regarding Drug Promotion in the United Kingdom and Sweden 2004–2012: A Quantitative and Qualitative Study of Pharmaceutical Industry Self-Regulation. PLOS Medicine 12:2, pages e1001785.
Crossref
Stuart S. Blume. (2013) Medical Innovations: Their Diffusion, Adoption, and Critical Interrogation. Sociology Compass 7:9, pages 726-737.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.